Arming T cells with activating FcγRIIIa receptors for antibody redirected lysis of cancer cells. (March 2018) - Jacobi, S.J.; Rataj, F.; Asang, F.; Stoiber, S.; Benmebarek, M.; Klaus, R.; Endres, S.; Klein, C.; Kobold, S.